{
  "metadata": {
    "generated_at": "2026-02-03T17:31:11.171770+00:00"
  },
  "ech0": {
    "baseline": {
      "shrinkage_percent": 83.5,
      "alive_cells": 165
    },
    "ech0_protocol": {
      "shrinkage_percent": 88.6,
      "alive_cells": 114,
      "field_schedule": [
        "glucose",
        "oxygen",
        "temperature",
        "lactate (cycle 2)"
      ]
    },
    "improvement_points": 5.099999999999994
  },
  "oncology": {
    "tumor_growth_cm3": {
      "day_0": 3.799999999999998,
      "day_90": 50.4128399495868,
      "day_180": 164.94067891784877
    },
    "drug_response": {
      "drug": "Erlotinib",
      "response_at_5uM": 0.041229828123505265
    },
    "combination_synergy": {
      "bliss_expected": 0.7525,
      "loewe_ci": 0.31578947368421056
    }
  },
  "clinical_trial": {
    "sample_size": 60,
    "response_rates": {
      "A": 0.625,
      "B": 0.7857142857142857
    },
    "assignments": {
      "A": 32,
      "B": 28
    }
  }
}